Frost Radar™：生命科學監管資訊管理平台，2026 年

Frost Radar(TM): Life Sciences Regulatory Information Management Platforms, 2026

出版日期: 2026年07月30日 | 出版商:

Frost & Sullivan | 英文 73 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

過去五年，生命科學領域的監管科技（RegTech）市場悄悄轉型，從以文件庫、申請準備和發布工具為主的後勤部門領域，發展成為支持製藥、生物技術和醫療設備業的關鍵軟體領域之一。 RegTech 起源於 1990 年代末，最初是一套用於編制 eCTD 申請的利基工具，如今已發展成為一個數十億美元的市場。雲端平台、人工智慧驅動的創建工具、監管資訊分析引擎和整合式資訊管理套件，構成了藥品和醫療設備從申請到全球註冊流程的核心。監管資訊管理（RIM）平台是監管合規營運的核心。它們將原本分散在不同系統中的功能——註冊和產品追蹤、申請規劃和發布、文件管理、監管溝通管理、視覺化和監管數據智慧——整合到一個互聯的環境中。企業需要的是可靠、集中化的監管資料視圖、無需人工重複輸入的端到端流程，以及隨時準備遵守監管機構不斷升級的資料標準的能力。近年來，人工智慧和智慧代理功能已開始被引入這些平台，但不同供應商的成熟度差異很大，許多宣傳的功能仍處於早期階段。在本期「Frost Radar」中，生命科學領域的監管技術指的是軟體、平台和技術驅動型服務，這些服務能夠幫助製藥、生物技術和學名藥公司規劃、準備、提交、追蹤和維護向衛生監管機構提交的監管文件，管理基礎產品、註冊和提交數據，並證明其符合全球市場的適用法規。此定義刻意涵蓋了純軟體供應商、結合諮詢和技術的混合型公司，以及具備監管合規模組、品管、臨床和生產能力的企業平台。

Frost & Sullivan公司對其所在行業的眾多公司進行分析。基於領導力及其他特徵，公司將被選中進行深入分析，並根據10項「成長與創新」標準進行基準評估，從而揭示其在Frost Radar™上的排名。本報告呈現了Frost Radar™上每家公司的競爭概況，分析了它們的優勢以及最適合發揮這些優勢的機會。

策略要務與成長環境

Frost Radar™：生命科學監管資訊管理平台

值得關注的公司

AmpleLogic
ArisGlobal
DDi
DXC Technology
Ennov
EXTEDO
Freyr
Generis
IQVIA
LORENZ Life Sciences
Veeva

最佳實踐和發展機遇

Frost Radar™ 分析

下一步：利用Frost Radar™ 為關鍵相關人員提供支持

被列入Frost Radar(TM) 的意義
CEO成長團隊
投資者
顧客
董事會

免責聲明

簡介目錄

Product Code: PLTC-52

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a niche set of tools to assemble eCTD dossiers has evolved into a multibillion-dollar landscape of cloud platforms, AI-enabled authoring tools, regulatory intelligence engines, and integrated information management suites that sit at the center of how a drug or device moves from filing to global registration. Regulatory information management (RIM) platforms have become central to how regulatory functions respond. They bring capabilities that used to sit in separate systems—registration and product tracking, submission planning and publishing, document management, health authority interaction management, labeling, and regulatory data intelligence—into a connected environment. What companies are looking for is a dependable single view of their regulatory data, processes that run end to end without manual rekeying, and readiness for the data standards that regulators are steadily introducing. More recently, AI and agentic capabilities are entering these platforms, though maturity varies widely between vendors and much of what is promoted remains at an early stage. For the purposes of this Frost Radar, regulatory technology in life sciences encompasses the software, platforms, and tech-enabled services that help pharmaceutical, biotech, and generics companies plan, prepare, submit, track, and maintain regulatory filings with health authorities; manage the underlying product, registration, and submission data; and demonstrate compliance with applicable regulations across global markets. That definition deliberately includes pure-play software vendors, hybrid consulting-plus-technology firms, and enterprise platforms whose regulatory modules sit alongside quality, clinical, or manufacturing capabilities.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.